Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis B Virus (HBV) Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04248426
What this trial is testing

Double-Blinded Study for Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ATI-2173 in Healthy Subjects and Subjects With Chronic Hepatitis B Virus Infection

Who this might be right for
Hepatitis B, Chronic
Antios Therapeutics, Inc 88
Early research (Phase 1)UnknownNCT03770624
What this trial is testing

Investigate the Safety, Efficacy and PK of Multiple Doses of QL-007 in Chronic Hepatitis B Patients in CHINA

Who this might be right for
Chronic Hepatitis b
Qilu Pharmaceutical Co., Ltd. 60
Not applicableUnknownNCT00845403
What this trial is testing

Antigen-specific Immune Response to Hepatitis B Virus in Utero

Who this might be right for
Hepatitis B
National University Hospital, Singapore 60
Not applicableUnknownNCT05967650
What this trial is testing

Efficacy of Accelerated Versus Standard Regiment of Hepatitis B Virus Vaccine Among Inflammatory Bowel Disease Patients

Who this might be right for
Inflammatory Bowel Diseases
Assiut University 200
Early research (Phase 1)UnknownNCT04277897
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics of Single and Multiple Doses of Hepenofovir Fumarate Tablets in Healthy Volunteers.

Who this might be right for
Chronic Hepatitis b
Xi'an Xintong Pharmaceutical Research Co.,Ltd. 69
Testing effectiveness (Phase 2)WithdrawnNCT06245291
What this trial is testing

Study of Imdusiran (AB-729) in Combination With Intermittent Dosing of Durvalumab in Subjects With Chronic HBV Infection

Who this might be right for
Hepatitis B, Chronic
Arbutus Biopharma Corporation
Large-scale testing (Phase 3)Ended earlyNCT00823342
What this trial is testing

ANRS HB 05 Multicenter Study Evaluating Efficacy and Safety of Clevudine Monotherapy Versus Tenofovir Monotherapy Versus Combination Therapy of Clevudine and Tenofovir for 96 Weeks in HBeAg Negative Patients With Chronic Hepatitis B, naïve to Anti-VHB Therapy

Who this might be right for
HBe Negative Chronic Hepatitis BHepatitis B Viral Infection
French National Agency for Research on AIDS and Viral Hepatitis 150
Post-approval studies (Phase 4)Study completedNCT00230061
What this trial is testing

Hepatitis B Vaccination in HIV-infected Persons

Who this might be right for
HIV InfectionsHepatitis B
Erasmus Medical Center 800
Testing effectiveness (Phase 2)Study completedNCT04980482
What this trial is testing

Open-Label Study of AB-729, Nucleos(t)Ide Analogue and Pegylated Interferon Alfa-2a in Subjects With Chronic Hepatitis B Infection

Who this might be right for
Chronic Hepatitis b
Arbutus Biopharma Corporation 43
Not applicableStudy completedNCT01645969
What this trial is testing

A Follow-Up Study of Patients With HBeAg Positive Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML22265

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 65
Not applicableStudy completedNCT01282762
What this trial is testing

Long-Term Study on Safety and Immunogenicity of HEPLISAV™ and Engerix-B® in Adults With Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
Dynavax Technologies Corporation 147
Early research (Phase 1)Active Not RecruitingNCT06989788
What this trial is testing

Evaluate the Safety and Immunogenicity of an Investigational Vaccine for Chronic Hepatitis B Virus Infection, in Healthy Adults

Who this might be right for
Chronic Hepatitis b
AstriVax Therapeutics 16
Not applicableStudy completedNCT03977857
What this trial is testing

Prediction Model Based on Computed Tomography Liver Volume for the Short-term Mortality in Hepatitis B Related Acute-on-Chronic

Who this might be right for
Acute-on-Chronic Liver FailureHepatitis B, Chronic
First Affiliated Hospital Xi'an Jiaotong University 486
Large-scale testing (Phase 3)Study completedNCT00197119
What this trial is testing

Long-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined Hepatitis A/B Vaccine Compared in Subjects Aged 12-15 Years

Who this might be right for
Hepatitis BHepatitis A
GlaxoSmithKline 244
Testing effectiveness (Phase 2)Study completedNCT01254994
What this trial is testing

The Efficacy and Safety of Entecavir Treatment of Patients With Acute on Chronic Hepatitis B Liver Failure

Who this might be right for
Liver Failure
Sun Yat-sen University 108
Not applicableStudy completedNCT01747772
What this trial is testing

Sonoelastography: Ultrasound Method to Measure Liver Fibrosis

Who this might be right for
Chronic Liver DiseaseNon-Alcoholic Fatty Liver DiseaseHepatitis C Virus (HCV) Coinfection+2 more
Massachusetts General Hospital 180
Not applicableLooking for participantsNCT04690972
What this trial is testing

"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".

Who this might be right for
Chronic Liver Disease and CirrhosisLiver CancerNon-Alcoholic Fatty Liver Disease+4 more
Institut National de la Santé Et de la Recherche Médicale, France 800
Post-approval studies (Phase 4)UnknownNCT03332329
What this trial is testing

Sequential/Combination Therapy in Nucleoside or Nucleotide Analogue (NA)-Suppressed Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis b
Qin Ning 15
Post-approval studies (Phase 4)Study completedNCT00240500
What this trial is testing

Follow-up Study 16-20 Years After Primary Vaccination Against Hepatitis B of Newborns From HBeAg+ & HBsAg+ Mothers

Who this might be right for
Hepatitis B
GlaxoSmithKline 109
Post-approval studies (Phase 4)Study completedNCT00230477
What this trial is testing

Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALT

Who this might be right for
Hepatitis B
University of Washington 19
Next Page